Neoadjuvant Chemo New SOC Option in Urothelial Carcinoma : v

Neoadjuvant chemotherapy in the high-risk population demonstrated favorable pathologic responses, and was well tolerated.

Related Keywords

Pennsylvania , United States , Fox Chase , Philadelphia , San Francisco , California , Daniel Geynisman , , Cancers Symposium , Fox Chase Cancer Center , Medscape Medical , Bladder Cancer , Alignant Bladder Neoplasm , Cancer , Alignant Neoplasia , Arcinoma , Neoadjuvant , Chemotherapy , Transitional Cell Carcinoma , Surgery , Tolerance , Drug Induced Toxicity , Hyperglycemia , Lymph Node Dissection , Lymphedema , Lymphoedema , Ymphatic Obstruction , Neutropenia ,